Biote Schedules Third Quarter 2022 Financial Results Release and Conference Call

Author's Avatar
Oct 31, 2022

biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leading provider of preventive health care through the delivery of personalized hormone therapy, today announced the Company will provide third quarter financial results on Tuesday, November 8, 2022, after the close of the market. A conference call to discuss the firm’s results will be held Wednesday, November 9, 2022 at 8:30 a.m. ET.